Earnings GuidanceMOH lowered FY25 EPS guidance an additional -14% following a previous revision, indicating increased financial pressure.
Medical Cost PressuresThe company is facing accelerating medical cost pressures across all business lines, impacting financial performance.
Utilization PressuresEstimates are lowered to reflect MOH's outlook of elevated utilization across all lines of business, especially in HIX.